HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 price target.